ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Universal Proptech Inc

Universal Proptech Inc (UPI)

0,03
0,00
(0,00%)
Fermé 05 Décembre 10:00PM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
0,03
Prix Achat
0,03
Prix Vente
0,035
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,03 Plage de 52 semaines 0,03
Cap du marché
Clôture Veille
0,03
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
49 217 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-18,75
Bénéfice par action (BPA)
-0
Chiffre d'affairess
3,2M
Bénéfice net
-80k

À propos de Universal Proptech Inc

Secteur
Prepackaged Software
Industrie
Air-cond,heating,refrig Eq
Siège social
Toronto, Ontario, Can
Fondé
2008
Universal Proptech Inc est coté dans le secteur Prepackaged Software de la TSX Venture Exchange avec le ticker UPI. Le dernier cours de clôture d'Universal Proptech était de $0,03. Au cours de la dernière année, les actions de Universal Proptech ont été négociées dans une fourchette de prix de $ 0,03 à $ 0,03.

Universal Proptech compte actuellement 49 217 000 actions en circulation. La capitalisation boursière d'Universal Proptech est de $1,48 million. Universal Proptech a un ratio cours/bénéfice (ratio PE) de -18.75.

UPI Dernières nouvelles

Universal PropTech Inc. Announces Delisting from the TSX Venture Exchange

TORONTO, June 12, 2024 (GLOBE NEWSWIRE) -- Universal PropTech Inc. ("UPI" or the "Company", TSXV: UPI.H) announces that the common shares of the Company are expected to be voluntarily delisted...

Uroplasty Reports Results For Third Quarter FY2010

- Strong Macroplastique(R) Year-over-Year U.S. Sales Growth - - Significant Publication & Presentation Schedule for Uroplasty Products - - Conference Call to be Held Today at 3:30 pm Central Time...

Uroplasty to Issue Third Fiscal Quarter Results on February 1, 2010

MINNEAPOLIS, Jan. 20 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI) announced today that it will release financial results for the third fiscal quarter ended December 31, 2009, at...

OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months

Significant symptom improvement from Uroplasty's Urgent(R) PC treatments previously demonstrated at 12 weeks continued at 12 months MINNEAPOLIS, Dec. 10 /PRNewswire-FirstCall/ -- Uroplasty, Inc...

Urgent(R) PC and Macroplastique(R) Abstracts Accepted for Presentation at Society for Urodynamics and Female Urology 2010 Annual

MINNEAPOLIS, Nov. 17 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (AMEX: UPI), a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of...

Uroplasty Reports Results for Second Quarter FY2010

- Macroplastique(R) Year-over-Year U.S. Sales Continue Strong Growth - - SUmiT Trial Results Recommended for Publication in Journal of Urology - - Conference Call to be Held Today at 3:30 pm...

Published Study Shows More Patients See Improvement in Overactive Bladder Symptoms With Urgent(R) PC Device Compared to Those Us

80% of Patients Treated with Urgent PC Reported Improvement Compared to 55% of Those Using an OAB Drug in a Study Published in September's Journal of Urology MINNEAPOLIS, Sept. 3...

Uroplasty Reports First Fiscal Quarter Results

- Macroplastique(R) year-over-year U.S. Sales Double - - SUmiT Trial Nears Completion - - Conference Call to be Held Today at 3:30 pm Central Time - MINNEAPOLIS, Aug. 3 /PRNewswire-FirstCall/...

Uroplasty to Issue First Fiscal Quarter Results on August 3, 2009

MINNEAPOLIS, July 27 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (AMEX:UPI) announced today that it will release financial results for the first fiscal quarter ended June 30, 2009, at the market...

Uroplasty Announces Patent Issuance Related to the Urgent(R) PC System

MINNEAPOLIS, July 13 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1000.030.030.0300CS
4000.030.030.0300CS
12000.030.030.0300CS
26000.030.030.0300CS
52000.030.030.0300CS
156-0.13-81.250.160.190.03354610.07889886CS
260-0.19-86.36363636360.220.750.03889860.26344771CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AAAAAuralite Investments Inc
$ 0,265
(0,00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0,035
(0,00%)
0
AAAlba Minerals Ltd
$ 0,03
(0,00%)
0
A.HArmor Minerals Inc
$ 0,43
(0,00%)
0
AArmor Minerals Inc
$ 0,45
(0,00%)
0
AAAAAuralite Investments Inc
$ 0,265
(0,00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0,035
(0,00%)
0
AAAlba Minerals Ltd
$ 0,03
(0,00%)
0
A.HArmor Minerals Inc
$ 0,43
(0,00%)
0
AArmor Minerals Inc
$ 0,45
(0,00%)
0
AAAAAuralite Investments Inc
$ 0,265
(0,00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0,035
(0,00%)
0
AAAlba Minerals Ltd
$ 0,03
(0,00%)
0
A.HArmor Minerals Inc
$ 0,43
(0,00%)
0
AArmor Minerals Inc
$ 0,45
(0,00%)
0
Aucune Discussion Trouvée
Ajouter une Discussion